Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013:2013:319898.
doi: 10.1155/2013/319898. Epub 2012 Aug 30.

Oxidative Stress and Its Clinical Applications in Dementia

Peizhong Mao  1
Affiliations
Review

Oxidative Stress and Its Clinical Applications in Dementia

Peizhong Mao. J Neurodegener Dis. 2013.

Abstract

Dementia is a complex disorder that mostly affects the elderly and represents a significant and growing public health burden in the world. Alzheimer's disease (AD)- associated dementia and dementia with Lewy bodies (DLB) are the most common forms of dementia, in which oxidative stress is significantly involved. Oxidative stress mechanisms may have clinical applications, that is, providing information for potential biomarkers. Thus brain-rich peptides with an antioxidant property, such as CART (cocaine- and amphetamine-regulated transcript), may be promising new markers. This paper summarizes the progress in research regarding oxidative stress in dementia with a focus on potential biomarkers in the cerebrospinal fluid (CSF) in the main forms of dementia. Other central and peripheral biomarkers, especially those considered oxidative stress related, are also discussed. This paper aims to provide information to improve current understanding of the pathogenesis and progression of dementia. It also offers insight into the differential diagnosis of AD and DLB.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Oxidative stress in MCI and Alzheimer's dementia.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Knopman D. S., DeKosky S. T., Cummings J. L., et al. Practice parameter: diagnosis of dementia (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology. Neurology. 2001;56(9):1143–1153. - PubMed
    1. Hyman B. T., Phelps C. H., Beach T. G., et al. National institute on aging-alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimer's & Dementia. 2012;8(1):1–13. - PMC - PubMed
    1. Schoonenboom N. S., Reesink F. E., Verwey N. A., et al. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology. 2012;78(1):47–54. - PubMed
    1. Lin M. T., Beal M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787–795. doi: 10.1038/nature05292. - DOI - PubMed
    1. Martin L. J. Mitochondrial and cell death nechanisms in neurodegenerative diseases. Pharmaceuticals (Basel) 2010;3(4):839–915. doi: 10.3390/ph3040839. - DOI - PMC - PubMed

LinkOut - more resources